Understanding TB Test Results and What They Mean

What a TB Test Does and Why It Matters

Tuberculosis (TB) is a serious infection caused by bacteria called Mycobacterium tuberculosis. The disease primarily affects the lungs, though it can spread to other parts of the body including bones, kidneys, and the brain. According to the World Health Organization, TB remains one of the top 10 causes of death worldwide, with approximately 10 million people developing TB disease each year.

A TB test is a screening tool that helps identify whether someone has been exposed to TB bacteria or has active TB disease. There are two main types of TB tests available in the United States: the tuberculin skin test (TST), also called the Mantoux test, and blood-based tests known as interferon-gamma release assays (IGRAs). Both tests work differently but serve the same general purpose—detecting TB infection.

TB testing is particularly important because TB infection doesn't always mean someone has active disease. When TB bacteria enter the body, a person may develop latent TB infection, meaning the bacteria are present but dormant, causing no symptoms and making the person unable to spread the disease to others. However, people with latent TB infection can develop active TB disease later in life, especially if their immune system becomes weakened.

Healthcare providers recommend TB testing for various situations. People who have had close contact with someone diagnosed with active TB should be tested. Healthcare workers, people living in congregate settings like shelters or correctional facilities, and individuals from countries with high TB rates may need testing as part of routine screening. Additionally, people with certain medical conditions that weaken the immune system, such as HIV or diabetes, should undergo TB testing.

Practical Takeaway: Understanding why you're being tested helps you know what to expect. TB tests are not diagnostic tests that confirm active disease by themselves—they indicate whether TB infection may be present, and further evaluation by a doctor is often necessary to determine what the results mean for your specific situation.

The Tuberculin Skin Test (TST) Explained

The tuberculin skin test, also known as the Mantoux test, is one of the oldest methods for detecting TB infection. A healthcare provider injects a small amount of purified protein derivative (PPD) into the skin, usually on the inner forearm. This injection is shallow and relatively painless. The test works by triggering an immune response in people who have been exposed to TB bacteria.

After receiving the injection, you must return to the healthcare facility 48 to 72 hours later for a reading. During this window, if you have TB infection, your immune system will have produced an inflammatory response at the injection site, creating a raised, hardened area called an induration. A healthcare provider measures the size of this induration in millimeters to determine the result. The measurement is crucial—it's not about whether there is a bump, but specifically how large the bump is.

One important detail about the TST is that the interpretation of results depends on several factors, particularly your risk level for TB disease. For people with no known risk factors, an induration of 15 millimeters or larger is typically considered a positive result. However, for people with HIV infection or other conditions affecting immunity, an induration of 5 millimeters or larger may be considered positive. For people with recent exposure to someone with active TB, an induration of 10 millimeters or larger may indicate infection. This means the same size bump could mean different things for different people.

The TST has some limitations. Certain vaccines, particularly the Bacille Calmette-Guérin (BCG) vaccine used in many countries outside the United States, can cause a positive TST result even in people without TB infection. Additionally, people with weakened immune systems might not develop a reaction even if they have TB infection. Some medications and certain illnesses can also affect test results. False positives and false negatives do occur, which is why doctors often use additional testing to clarify results.

Practical Takeaway: If you receive a TST, mark your calendar for the 48 to 72-hour follow-up appointment—missing this window means the test is invalid and you'll need to start over. The size of any bump matters more than its appearance, so a healthcare provider must measure it properly for accurate interpretation.

Understanding Blood Tests for TB (IGRA Tests)

Interferon-gamma release assays, commonly called IGRA tests or TB blood tests, offer an alternative to the skin test for detecting TB infection. These tests measure the immune system's response to TB antigens by analyzing blood samples. The most commonly used IGRA tests in the United States are the QuantiFERON test (in various versions) and the T-SPOT test. Unlike the skin test, blood tests provide results in a laboratory rather than requiring a follow-up visit.

IGRA tests work on a different principle than TST. A blood sample is drawn and then exposed in the laboratory to specific TB antigens. If a person has been infected with TB, white blood cells in the sample will release interferon-gamma, a chemical messenger the immune system produces in response to TB bacteria. The test measures the amount of this interferon-gamma released. Higher levels suggest TB infection, while low or undetectable levels suggest the person has not been infected.

The CDC now recommends IGRA tests as the preferred screening method in most situations, particularly in the United States. There are several advantages to IGRA tests compared to TST. People who received the BCG vaccine will typically have a negative IGRA result, avoiding the false-positive results that commonly occur with skin tests. IGRA tests require only one visit to draw blood, whereas TST requires two visits. Results are usually available within a few days rather than 48 to 72 hours. Additionally, IGRA tests are not affected by previous BCG vaccination or certain non-tuberculous mycobacteria.

However, IGRA tests also have limitations. They cannot be performed in certain settings without laboratory facilities. They can produce indeterminate results, meaning the test did not provide a clear positive or negative answer—this occurs in roughly 1 to 5 percent of tests depending on the specific test used. People with severely weakened immune systems might have false-negative results. The cost of IGRA tests is often higher than TST, though many insurance plans cover them. Healthcare providers may still recommend TST in certain populations or situations despite the general preference for IGRA.

Practical Takeaway: IGRA tests require proper timing for blood collection and may not be available in all healthcare settings. If you receive an IGRA test, ask about the timeline for results and whether you should follow up if you don't receive results within the expected timeframe.

Interpreting Positive TB Test Results

A positive TB test result means that TB infection is likely present—either latent TB infection or possibly active TB disease. However, the test result alone does not indicate which type of infection you have or whether you are contagious. This is a critical distinction that many people misunderstand. A positive test is the beginning of further evaluation, not a diagnosis of active TB disease.

When you receive a positive TB test result, your healthcare provider will conduct additional evaluations. These typically include a detailed medical history exploring any symptoms you may have experienced, such as cough lasting more than three weeks, chest pain, coughing up blood, fever, chills, or night sweats. Your provider will ask about your TB exposure history and risk factors. A chest X-ray is almost always recommended to look for signs of active TB disease in the lungs. Sometimes a sputum smear test—where you cough up mucus that is examined under a microscope for TB bacteria—is performed to determine if you have active disease and are contagious.

The distinction between latent and active TB is essential. If your test is positive but your chest X-ray is normal and you have no symptoms, you likely have latent TB infection. People with latent TB infection cannot spread TB to others. However, without treatment, about 5 to 10 percent of people with latent TB infection will develop active TB disease at some point in their lives, according to the CDC. If you have latent TB infection, your healthcare provider may discuss whether preventive medication is appropriate for you based on your age, immune status, and other risk factors.

If your positive TB test is accompanied by symptoms, an abnormal chest X-ray, or positive sputum test results, you likely have active TB disease. This requires prompt treatment with specific anti-TB medications, typically a combination of four different drugs taken for at least six months. Active TB disease is